MLICM
APLT

Metropolitan Life Insurance Company (MetLife)’s Applied Therapeutics APLT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,405
Closed -$89.7K – 2783
2021
Q3 		$89.7K Hold
5,405
– – ﹤0.01% 2585
2021
Q2 		$112K Buy
5,405
+4,480
+484% +$84.8K ﹤0.01% 2534
2021
Q1 		$17.3K Sell
925
-3,442
-79% -$74.3K ﹤0.01% 2576
2020
Q4 		$96.1K Buy
4,367
+22
+0.5% +$458 ﹤0.01% 2375
2020
Q3 		$90.2K Hold
4,345
– – ﹤0.01% 2275
2020
Q2 		$157K Buy
4,345
+1,794
+70% +$75.1K ﹤0.01% 1972
2020
Q1 		$83.4K Buy
+2,551
New +$103K ﹤0.01% 2148

Other funds holding APLT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s APLT Position: Q4 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Applied Therapeutics (APLT) in Q4 2021, closing a stake of 5,405 shares — an estimated $89.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in APLT in Q1 2020 and held it in 7 quarters. The position peaked at $157K in Q2 2020. 69 funds tracked by Wall St. Rank hold APLT as of Q4 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Applied Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 5,405 Applied Therapeutics shares in Q4 2021, an estimated $89.7K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Applied Therapeutics in Q1 2020 and held it in 7 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Applied Therapeutics position peaked at $157K in Q2 2020.
  • 69 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.